New guidelines for hypertrophic cardiomyopathy: the impact on prophylactic cardioverter-defibrillator implantation

被引:0
|
作者
Godinho, A. R. [1 ]
Vasconcelos, M. [1 ]
Rangel, I. [1 ]
Araujo, V. [1 ]
Frutuoso, C. [1 ]
Cardoso, J. S. C. [1 ]
Maciel, M. J. [1 ]
机构
[1] Univ Porto, Cardiol, P-4100 Oporto, Portugal
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P1460
引用
收藏
页码:307 / 307
页数:1
相关论文
共 50 条
  • [1] Timing of Prophylactic Implantable Cardioverter-Defibrillator Implantation in Patients With Cardiomyopathy
    Littmann, Laszlo
    Narveson, Sara Y.
    Fesel, Nicole M.
    Marconi, Sarah L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (01): : 161 - 162
  • [2] Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator
    Manovel-Sanchez, Ana J.
    Pedrote-Martinez, Alonso
    Arana-Rueda, Eduardo
    de Tejada, Francisco Errazquin-Saenz
    REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (07): : 784 - 784
  • [3] Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy
    Almquist, AK
    Montgomery, JV
    Haas, TS
    Maron, BJ
    HEART RHYTHM, 2005, 2 (08) : 814 - 819
  • [4] Recommendations of the current guidelines for implantable cardioverter-defibrillator implantation in patients with hypertrophic cardiomyopathy: Debate still exists
    Arya Aminorroaya
    Ali Vasheghani-Farahani
    Farzad Masoudkabir
    Pegah Roayaei
    Journal of Interventional Cardiac Electrophysiology, 2021, 60 : 1 - 7
  • [5] Recommendations of the current guidelines for implantable cardioverter-defibrillator implantation in patients with hypertrophic cardiomyopathy: Debate still exists
    Aminorroaya, Arya
    Vasheghani-Farahani, Ali
    Masoudkabir, Farzad
    Roayaei, Pegah
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2021, 60 (01) : 1 - 7
  • [6] Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator -: Response
    Marin, Francisco
    Gimeno, Juan R.
    Martinez, Juan G.
    Monserrat, Lorenzo
    REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (07): : 785 - 785
  • [7] Hypertrophic cardiomyopathy: Role of the implantable cardioverter-defibrillator
    Primo, J
    Geelen, P
    Brugada, J
    Lorga, A
    Mont, L
    Wellens, F
    Valentino, M
    Brugada, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (05) : 1081 - 1085
  • [8] The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy
    Zhu, DWX
    Sun, HB
    Hill, R
    Roberts, R
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1998, 21 (01): : 299 - 302
  • [9] Implantable cardioverter-defibrillator in pregnant women with hypertrophic cardiomyopathy
    Cordeiro de Paula, Leonardo Jorge
    Ribeiro, Henrique Barbosa
    de Oliveira Junior, Roberto Marcio
    da Silva, Katia Regina
    REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR, 2010, 25 (03): : 406 - 409
  • [10] Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy
    Francia, Pietro
    Adduci, Carmen
    Palano, Francesca
    Semprini, Lorenzo
    Serdoz, Andrea
    Montesanti, Dalma
    Santini, Daria
    Musumeci, Beatrice
    Salvati, Adriano
    Volpe, Massimo
    Autore, Camillo
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2015, 26 (08) : 893 - 899